Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results.
about
Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Sustained deep molecular respo ...... Tcmr randomized trial results.
@en
Sustained deep molecular respo ...... Tcmr randomized trial results.
@nl
type
label
Sustained deep molecular respo ...... Tcmr randomized trial results.
@en
Sustained deep molecular respo ...... Tcmr randomized trial results.
@nl
prefLabel
Sustained deep molecular respo ...... Tcmr randomized trial results.
@en
Sustained deep molecular respo ...... Tcmr randomized trial results.
@nl
P2093
P2860
P50
P356
P1433
P1476
Sustained deep molecular respo ...... STcmr randomized trial results
@en
P2093
A Guerci-Bresler
A P Schwarer
F Cervantes
J H Lipton
N C D Clementino
P E Dorlhiac-Llacer
P2860
P2888
P304
P356
10.1038/LEU.2017.247
P577
2017-08-03T00:00:00Z